A Retrospective Analysis of VeriStrat Status on Outcome of a Randomized Phase II Trial of First-Line Therapy with Gemcitabine, Erlotinib, or the Combination in Elderly Patients (Age 70 Years or Older) with Stage IIIB/IV Non-Small-Cell Lung Cancer Article Proceedings Paper

cited authors

  • Stinchcombe, Thomas E.; Roder, Joanna; Peterman, Amy H.; Grigorieva, Julia; Lee, Carrie B.; Moore, Dominic T.; Socinski, Mark A.

authors

Publication Date

  • April 1, 2013

webpage

published in

category

keywords

  • Biomarkers
  • Elderly
  • Epidermal growth factor receptor tyrosine kinase inhibitors
  • Proteomics

start page

  • 443

end page

  • 451

volume

  • 8

issue

  • 4